SiriusPoint
SPNT
24.62
+0.01
+0.04%
SiriusPoint
US · SPNT
#2530 by market cap
Listed 1970
24.62
+0.01
+0.04%
Live - 5344 symbols - heartbeat 259s ago
· 2026-10-08 04:03
Pre-market
24.64
+0.07%
After-hours
24.62
0.00%
- Market cap
- 2.86B
- P/E (TTM)i
- 6.06
- P/Bi
- 1.26
- EPSi
- 3.64
- Div yieldi
- 0.00%
- 52W posi
- 79%
Reader sentiment
Are you bullish or bearish on SPNT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions increased by 1 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.4 percentage points.
Institutional ownership
- Held by institutions
- 93.11% -0.40pp
- Institutions
- 307 +1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund78.90%
Hedge Fund8.77%
Individual/Insider6.00%
Public Company2.52%
Government Pension Fund1.48%
Private Company0.69%
Insurance Company0.55%
Family Office/Trust0.12%
Other0.92%
Top holders as of 2026-06-30
BlackRock
9.75% · 11.33M sh
Dimensional Fund Advisors
6.29% · 7.31M sh
Third Point LLC
6.29% · 7.30M sh
Vanguard Portfolio Management, LLC
5.67% · 6.58M sh
Donald Smith & Co., Inc.
5.31% · 6.16M sh
American Century Investment Management
4.79% · 5.57M sh
Vanguard Capital Management, LLC
4.68% · 5.44M sh
Capital Research
4.27% · 4.97M sh
State Street Global Advisors
4.19% · 4.87M sh
Daniel Loeb
3.24% · 3.76M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 27 buys · 23 sells
| Name | Role | Stake |
|---|---|---|
| Daniel Loeb | Director | 3.24% |
| Scott Egan | Chief Executive Officer | 1.15% |
| David Govrin | Group President & Chief Underwriting Officer | 0.54% |
| Thomas Leonardo | Global Head of Accident & Health (A&H) | 0.19% |
| Sharon Ludlow | Independent Director | 0.14% |
| Patrick Charles | -- | 0.13% |
| Robin John Gibbs | President & CEO of SiriusPoint International | 0.12% |
| Mehdi Mahmud | Independent Director | 0.11% |
| Jason Robart | Independent Director | 0.08% |
| Franklin Montross | Independent Director | 0.08% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-30 | Thomas Leonardo | Global Head of Accident & Health (A&H) | Sale to Issuer | -1,702 | $24.18 |
| 2026-05-30 | James McKinney | Chief Financial Officer | Sale to Issuer | -3,648 | $21.35 |
| 2026-05-28 | Bronislaw Masojada | Independent Chairperson | Other Acquisition | +5,903 | $23.29 |
| 2026-05-28 | Susan Cross | Director | Other Acquisition | +5,903 | $23.29 |
| 2026-05-28 | Mehdi Mahmud | Independent Director | Other Acquisition | +5,903 | $23.29 |
| 2026-05-28 | Sabra Purtill | Director | Other Acquisition | +5,903 | $23.29 |
| 2026-05-28 | Jason Robart | Independent Director | Other Acquisition | +5,903 | $23.29 |
| 2026-05-28 | Sharon Ludlow | Independent Director | Other Acquisition | +5,903 | $23.29 |
| 2026-05-28 | Martin Hudson | Director | Other Acquisition | +5,903 | $23.29 |
| 2026-05-10 | Scott Egan | Chief Executive Officer | Other Acquisition | +16,582 | -- |
| 2026-05-10 | Scott Egan | Chief Executive Officer | Other Disposition | -16,582 | -- |
| 2026-04-29 | David Govrin | Group President & Chief Underwriting Officer | Sale to Issuer | -4,488 | $23.29 |
| 2026-04-29 | Scott Egan | Chief Executive Officer | Sale to Issuer | -4,247 | $23.29 |
| 2026-04-29 | Thomas Leonardo | Global Head of Accident & Health (A&H) | Sale to Issuer | -2,413 | $23.29 |
| 2026-04-29 | James McKinney | Chief Financial Officer | Sale to Issuer | -2,620 | $23.29 |
| 2026-04-29 | Robin John Gibbs | President & CEO of SiriusPoint International | Sale to Issuer | -2,174 | $23.29 |
| 2026-04-29 | Patrick Charles | -- | Sale to Issuer | -1,068 | $23.29 |
| 2026-04-29 | Anthony Shapella | Deputy Chief Underwriting Officer | Sale to Issuer | -911 | $23.29 |
| 2026-04-27 | David Govrin | Group President & Chief Underwriting Officer | Other Acquisition | +19,926 | -- |
| 2026-04-27 | Scott Egan | Chief Executive Officer | Other Acquisition | +48,625 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 04:03:22 · For reference only, not investment advice and not tailored to your situation.